June 22, 2025 - 13:42

DXC Technology has demonstrated some stabilization recently, as evidenced by improved bookings, but it continues to grapple with declining revenue and margins. The company has been working diligently to navigate a challenging market landscape, focusing on enhancing its service offerings and operational efficiency.
Despite the positive trend in bookings, which suggests a potential turnaround, the overall financial performance remains a concern. Revenue figures have not shown the necessary growth, and margins are under pressure, prompting the need for strategic adjustments.
Investors are closely monitoring DXC's efforts to revamp its business model and implement cost-saving measures. The company's leadership remains optimistic about the future, emphasizing their commitment to driving innovation and improving customer satisfaction. As DXC Technology moves forward, stakeholders will be keen to see if these initiatives can translate into sustainable growth and a more robust financial outlook.
April 10, 2026 - 03:59
Verneek's Deep Technology Tackles Retail IssuesThe retail sector is turning to sophisticated artificial intelligence to solve persistent operational challenges, with companies like Verneek at the forefront. According to its CEO, Dr. Nasrin...
April 9, 2026 - 12:09
California lawmaker introduces bill to help prevent, de-escalate police chases with new technologyIn a direct response to the dangers of high-speed police pursuits, a California lawmaker has introduced new legislation focused on de-escalation and prevention. The bill arrives amid heightened...
April 8, 2026 - 20:04
Omatic Releases Fourth Annual Nonprofit Technology Ecosystem Trends Report, Uncovers a Sector Drowning in Data—And the Struggle to Trust ItA comprehensive new survey of over 800 nonprofit professionals has uncovered a sector at a critical technological crossroads, grappling with an overwhelming influx of data while simultaneously...
April 8, 2026 - 08:38
Halozyme and Vertex sign deal for Hypercon technologyIn a significant move within the biopharmaceutical industry, Halozyme Therapeutics has entered into an exclusive worldwide partnership and licensing agreement with Vertex Pharmaceuticals. The multi...